Optical Tomography in Prostate Cancer

Completed · Not applicable

Conditions studied: Prostate Cancer

In brief

This study is looking to see if a new device, diffuse optical tomography (DOT), can detect prostate cancer. The investigators will also see if DOT can tell the difference between high risk and low risk prostate cancers.

Key facts

Study ID

NCT03215992

Run by

Columbia University

People needed

9

Starts

2016-06-13

Expected to finish

2018-02-08

Last updated by the study team

2018-08-02

Who can join

Age: 18 and older, up to 99. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Men 18 years of age or older scheduled for transrectal prostate biopsy or radical prostatectomy at Columbia University Medical Center
• Signing consent for study imaging procedure and analysis of prostate biopsy

You may not qualify if…

• Patients failing to meet the inclusion criteria
• Contraindication for magnetic resonance imaging

Where it is running

• Columbia University Medical Center — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.